Display options
Share it on

Korean J Hepatobiliary Pancreat Surg. 2014 Feb;18(1):33-7. doi: 10.14701/kjhbps.2014.18.1.33. Epub 2014 Feb 24.

AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer.

Korean journal of hepato-biliary-pancreatic surgery

Chang Young Kim, Sung Hwan Lee, Hyae Min Jeon, Hyun Ki Kim, Chang Moo Kang, Woo Jung Lee

Affiliations

  1. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
  2. Department of Surgery, Yonsei University College of Medicine, Seoul, Korea. ; Pancreaticobiliary Cancer Clinic, Institute of Gastroenterology, Yonsei University Severance Hospital, Seoul, Korea.
  3. Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.

PMID: 26155245 PMCID: PMC4492330 DOI: 10.14701/kjhbps.2014.18.1.33

Abstract

We report a case of alpha-fetoprotein (AFP)-producing acinar cell carcinoma (ACC) of the pancreas. The tumor was diagnosed in a 72 yearold female after radical subtotal gastrectomy (Billroth I) due to early gastric cancer six months before. The initial serum AFP levels were increased to 2,254.1 IU/ml and preoperative imaging studies showed a mass with approximately 2.5 cm in diameter near the neck of the pancreas. A pancreaticoduodenectomy was performed. The pathologic examination revealed an ill-defined lobulating tumor confined to the pancreas (T1 stage). Immunohistochemical study showed that the tumor cells expressed AFP. The Adenosine triphosphate-based chemotherapy response assay (ATP-CRA) suggested that cisplatin would be more desirable than gemcitabine in AFP-producing ACC of the pancreas as an adjuvant chemotherapy. However, the adjuvant chemotherapy was not performed due to the early pathological stage. The patient died from carcinomatosis and pneumonia. Even if the tumor was on a relatively early stage, an adjuvant treatment should be considered ACC.

Keywords: Acinar cell carcinoma; Alpha-fetoprotein; Gastric cancer; Pancreatectomy

References

  1. J Pathol. 1985 May;146(1):17-29 - PubMed
  2. Eur J Radiol. 1995 Nov;21(1):58-60 - PubMed
  3. Eur J Cancer. 1997 May;33(6):960-6 - PubMed
  4. Breast. 2008 Feb;17(1):19-26 - PubMed
  5. Surgery. 2008 Aug;144(2):141-8 - PubMed
  6. Pancreatology. 2007;7(4):370-2 - PubMed
  7. Anticancer Res. 1995 Jul-Aug;15(4):1491-9 - PubMed
  8. Gynecol Oncol. 2000 Mar;76(3):405-8 - PubMed
  9. Hum Pathol. 2000 Aug;31(8):938-44 - PubMed
  10. Hepatogastroenterology. 1992 Jun;39(3):282-6 - PubMed
  11. Korean J Gastroenterol. 2010 Apr;55(4):245-51 - PubMed
  12. J Clin Oncol. 1997 Jun;15(6):2403-13 - PubMed
  13. Chir Ital. 2000 May-Jun;52(3):263-70 - PubMed

Publication Types